Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Here are some of the largest recent moves: LPL FINANCIAL LLC added 158,405 shares (+301.0%) to their portfolio in Q4 2024, for an estimated $2,776,839 CAPITAL MANAGEMENT CORP /VA removed 118,345 shares (-28.2%) from their portfolio in Q4 2024, for an estimated $2,074,587 ENVESTNET ASSET MANAGEMENT INC removed 76,629 shares (-34.4%) from their portfolio in Q4 2024, for an estimated $1,343,306 SUSQUEHANNA INTERNATIONAL GROUP, LLP added 71,979 shares (+128.3%) to their portfolio in Q4 2024, for an estimated $1,261,791 EAM INVESTORS, LLC added 60,243 shares (+inf%) to their portfolio in Q4 2024, for an estimated $1,056,059 683 CAPITAL MANAGEMENT, LLC added 49,500 shares (+inf%) to their portfolio in Q4 2024, for an estimated $867,735 RENAISSANCE TECHNOLOGIES LLC removed 47,300 shares (-5.7%) from their portfolio in Q4 2024, for an estimated $829,169 To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard
Body composition and fat Growth hormone influences how the body uses fat for energy, which is why fat loss and belly fat come up so often
Studies such as SURPASS 15 and J-mono have demonstrated that tirzepatide is more effective than other therapy alternatives in reducing HbA1C levels [84, 85]
Glucose regulation beyond HbA 1c in type 2 diabetes treated with insulin: real-world evidence from the DIALECT-2 cohort
Avoid platforms that: Do not require provider review Cannot identify their pharmacy Cannot provide a Certificate of Analysis Offer suspiciously cheap pricing Provide no ongoing monitoring Can I use insurance
Disclaimer: Retatrutide is supplied strictly for laboratory research use only
